Crotalus species snake venom toxins

Crotalus species snake venom toxins represent a complex mixture of bioactive proteins and peptides found in rattlesnakes, primarily functioning to immobilize and digest prey (NCBI: Venom of Crotalus species, 2021). These toxins include snake venom metalloproteinases (SVMPs), phospholipases A2 (PLA2), serine proteases, and disintegrins, which collectively disrupt the circulatory, nervous, and muscular systems of the victim. SVMPs are largely responsible for local tissue necrosis and systemic hemorrhage by degrading extracellular matrix components and vascular basement membranes (StatPearls: Snake Toxicity, 2023). PLA2 enzymes contribute to myotoxicity and neurotoxicity, while serine proteases often interfere with the coagulation cascade, leading to consumption coagulopathy. In clinical medicine, these toxins are the primary targets for antivenom therapies, such as CroFab and Anavip, which utilize purified antibody fragments to neutralize the venom's enzymatic and toxic activities (FDA: CroFab Prescribing Information). Understanding the specific composition of Crotalus venom is critical for managing snakebite envenomation and developing more effective, species-specific treatments.

Other names

Rattlesnake venomCrotalid venomCrotalus toxins

Antivenoms consist of purified antibody fragments (Fab or F(ab')2) that bind to and neutralize the circulating venom toxins, thereby preventing their interaction with host tissues and facilitating their clearance from the systemic circulation (StatPearls: Snake Antivenom, 2023; FDA: CroFab Label).